受强制性开放获取政策约束的文章 - Javier Martín Broto了解详情
无法在其他位置公开访问的文章：9 篇
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ...
The Lancet 394 (10197), 478-487, 2019
强制性开放获取政策： US National Institutes of Health
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
A Gronchi, E Palmerini, V Quagliuolo, J Martin Broto, A Lopez Pousa, ...
Journal of Clinical Oncology 38 (19), 2178-2186, 2020
强制性开放获取政策： National Institute of Health and Medical Research, France
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
J Martin-Broto, J Cruz, N Penel, A Le Cesne, N Hindi, P Luna, DS Moura, ...
The Lancet Oncology 21 (3), 456-466, 2020
强制性开放获取政策： European Commission, Government of Spain
RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomas
A Obrador-Hevia, E Martinez-Font, I Felipe-Abrio, S Calabuig-Fariñas, ...
Cancer investigation 33 (9), 440-450, 2015
强制性开放获取政策： Government of Spain
Phase II study of Gemcitabine Plus Sirolimus in previously treated patients with advanced soft-tissue sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
J Martin-Liberal, A López-Pousa, J Martínez-Trufero, J Martín-Broto, ...
Targeted Oncology 13, 81-87, 2018
强制性开放获取政策： Government of Spain
Neoadjuvant chemotherapy in high-grade myxoid liposarcoma: results of the expanded cohort of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish …
A Gronchi, E Palmerini, V Quagliuolo, J Martin Broto, A Lopez Pousa, ...
Journal of Clinical Oncology 42 (8), 898-906, 2024
强制性开放获取政策： National Institute of Health and Medical Research, France
Predictive value of MRP-1 in localized high-risk soft tissue sarcomas: a translational research associated to ISG-STS 1001 randomized phase III trial
J Martin-Broto, M Lopez-Alvarez, DS Moura, R Ramos, P Collini, ...
Molecular Cancer Therapeutics 20 (12), 2539-2552, 2021
强制性开放获取政策： National Institute of Health and Medical Research, France, Cancer Research …
Phase ib study for the combination of doxorubicin, dacarbazine, and nivolumab as the upfront treatment in patients with advanced leiomyosarcoma: a study by the Spanish sarcoma …
J Martin-Broto, R Diaz-Beveridge, D Moura, R Ramos, J Martinez-Trufero, ...
Journal of Clinical Oncology, JCO. 24.00358, 2024
强制性开放获取政策： Cancer Research UK, European Commission
Shared germline genomic variants in two patients with double primary gastrointestinal stromal tumours (GISTs)
DS Moura, DL López, D di Lernia, M Martin-Ruiz, M Lopez-Alvarez, ...
Journal of Medical Genetics 61 (10), 927-934, 2024
强制性开放获取政策： European Commission
可在其他位置公开访问的文章：74 篇
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
强制性开放获取政策： Government of Spain
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a …
JS Gold, M Gönen, A Gutiérrez, JM Broto, X García-del-Muro, TC Smyrk, ...
The lancet oncology 10 (11), 1045-1052, 2009
强制性开放获取政策： US National Institutes of Health
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ...
Annals of oncology 33 (1), 20-33, 2022
强制性开放获取政策： Government of Spain
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ...
Annals of Oncology 32 (12), 1520-1536, 2021
强制性开放获取政策： Government of Spain
Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial
WD Tap, AJ Wagner, P Schöffski, J Martin-Broto, A Krarup-Hansen, ...
Jama 323 (13), 1266-1276, 2020
强制性开放获取政策： US National Institutes of Health
Ultra‐rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
S Stacchiotti, AM Frezza, JY Blay, EH Baldini, S Bonvalot, JVMG Bovée, ...
Cancer 127 (16), 2934-2942, 2021
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
GD Demetri, CR Antonescu, B Bjerkehagen, JVMG Bovee, K Boye, ...
Annals of Oncology 31 (11), 1506-1517, 2020
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ...
ESMO open 6 (3), 100170, 2021
强制性开放获取政策： US National Institutes of Health
A comprehensive review on solitary fibrous tumor: new insights for new horizons
J Martin-Broto, JL Mondaza-Hernandez, DS Moura, N Hindi
Cancers 13 (12), 2913, 2021
强制性开放获取政策： European Commission, Government of Spain
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours–EURO EWING 2012 Protocol
J Anderton, V Moroz, P Marec-Bérard, N Gaspar, V Laurence, ...
Trials 21, 1-9, 2020
强制性开放获取政策： Cancer Research UK, Swiss Cancer League
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery
H Joensuu, J Martin-Broto, T Nishida, P Reichardt, P Schöffski, RG Maki
European Journal of Cancer 51 (12), 1611-1617, 2015
强制性开放获取政策： Academy of Finland
出版信息和资助信息由计算机程序自动确定